This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Bergen County-based Bio-Reference Donates $100,000 To Hurricane Sandy New Jersey Relief Fund

Stocks in this article: BRLI

ELMWOOD PARK, N.J., Dec. 18, 2012 /PRNewswire/ --  Bio-Reference Laboratories, Inc. (NASDAQ: BRLI), a national clinical testing laboratory, has announced its donation of $100,000 to the Hurricane Sandy New Jersey Relief Fund.  The Fund has been established to help New Jersey citizens rebuild after the devastation caused last month by the storm.

"There are moments when we are confronted with events so overwhelming and destructive that the question is not whether we should help but rather how can we not help. Hurricane Sandy provided one of those moments.  Those affected were our neighbors, friends, and co-workers.  Experiencing the devastation that was Hurricane Sandy in our own state has hit home with the entire Bio-Reference family," stated Marc Grodman, MD, President and CEO of Bio-Reference Laboratories.  "Our business may be national in scope, but we remain a New Jersey-based company and we could not stand by doing nothing while witnessing the impact to families and small business owners all around us – especially in our immediate neighborhood of Bergen County, where communities still are struggling to recover."

Hurricane Sandy New Jersey Relief Fund Inc. is a private independent charitable organization that is registered with the Charities Registration and Investigation Section of the Division of Consumer Affairs under the Attorney General of the State of New Jersey.

"We employ more than 3,500 people at Bio-Reference Laboratories, most of whom live in New Jersey, many who live in this immediate area.  Every one of us has a family member or friend affected by the storm – while others were impacted directly," added Grodman.  "We hope that, through the Hurricane Sandy New Jersey Relief Fund, we can help to rebuild our communities and help those families most in need who might otherwise fall through the cracks and not receive the kind of assistance they require to rebuild."

About Bio-Reference Laboratories, Inc. BRLI is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units.  We believe that we are the fourth largest full-service laboratory in the United States and the largest independent regional laboratory in the Northeastern market.  BRLI offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.  BRLI primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, women's health and correctional health care.

Statements included in this release that are not historical in nature are intended to be, and are hereby identified as, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will" or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of Bio-Reference Laboratories, Inc. and its subsidiaries. Such statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to be materially different from any future performance suggested herein. Risks and uncertainties that may affect the future results of the Company include, but are not limited to, adverse results from failure to comply with applicable laws and regulations governing our business or government investigations, lawsuits or private actions, the competitive environment, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other risks and uncertainties detailed from time to time in our filings with the Securities and Exchange Commission.  We undertake no obligation to publicly update or review any forward-looking information, whether as a result of new information, future developments or otherwise.

SOURCE Bio-Reference Laboratories, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,315.70 -101.15 -0.58%
S&P 500 2,003.21 -18.04 -0.89%
NASDAQ 4,662.8190 -20.5880 -0.44%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs